View Article

Abstract

Inflammation is a complex biological response that protects the body against infection, injury, and tissue damage. However, prolonged inflammatory processes are associated with several chronic diseases, creating a need for the development of safer and more effective anti-inflammatory agents. In the present study, two novel 1,3,4-oxadiazole derivatives, namely 2-phenyl-5-(benzylideneamino)-1,3,4-oxadiazole (Compound A) and 2-phenyl-5-(phenylhydrazino)-1,3,4-oxadiazole (Compound B), were synthesized using simple and economical synthetic routes. The synthesized compounds were isolated, purified, and characterized through physicochemical evaluation, qualitative chemical tests, FT-IR spectroscopy, ¹H NMR, ¹³C NMR, and mass spectrometric analysis. Compound A exhibited a percentage yield of 84%, whereas Compound B showed a yield of 71%. Spectral data confirmed the successful formation of the oxadiazole nucleus and the presence of the expected functional groups. Both compounds displayed characteristic absorption bands and resonance signals corresponding to aromatic rings, nitrogen-containing functionalities, and heterocyclic structures. The findings demonstrate the successful synthesis and structural confirmation of novel oxadiazole derivatives, which may serve as promising candidates for further investigation as anti-inflammatory agents.

Keywords

1,3,4-Oxadiazole,Anti-inflammatory Agents,FT-IR, NMR Spectroscopy, Mass Spectrometry, Oxadiazole Derivatives, Medicinal Chemistry

Introduction

× Popup Image

Inflammation is a protective physiological response that occurs in vascularized tissues when they are exposed to harmful agents such as microorganisms, toxins, injured cells, or physical trauma. It maintains normal tissue function and is a crucial part of the body's defence mechanism. The inflammatory process is designed to remove the source of injury, clear damaged cellular components, and promote tissue healing and regeneration. While inflammation is beneficial for host protection and recovery, prolonged or uncontrolled inflammatory responses can contribute to disease development. Persistent inflammation is associated with numerous chronic disorders, including rheumatoid arthritis, osteoarthritis, cardiovascular diseases, inflammatory bowel disorders, asthma, neurodegenerative conditions, and various forms of cancer. Therefore, effective regulation of inflammatory pathways is crucial for maintaining overall health and preventing disease progression.[‘2.3]

1 General Structure of Oxadiazole[7]                            

 2 Isomeric Forms of Oxadiazole[6]  

1,2,3-Oxadiazole, 1,2,4-Oxadiazole, 1,2,5-Oxadiazole, 1,3,4-Oxadiazole

Biological Activities of Oxadiazole Derivatives [4’5]   

MATERIALS AND METHODS: -

Table No. 1 Chemicals List

Sr.No

Chemical Name

Manufacturer

1

Distilled Water

Research Labs.

2

Benzaldehyde

Research Labs.

3

Ammonium Solution

Research Labs.

4

Glacial Acetic acid

Research Labs.

5

Phenylhydrazine hydrochloride.

Research Labs.

6

Benzamide

Research Labs.

7

Ethanol

Research Labs.

8

Ammonium acetate

Research Labs.

9

1.2,4-Dinitrophenylhydrazine

Research Labs.

10

Phatalic Anhydrid

Research Labs

SYNTHESIS  PROCEDURE 

Compound A: 2phenyl-5-benzylideneamino-1,3,4-oxadiazole Procedure:

Step 1: Benzaldehyde Oxime Formation 

  1. Dissolve 0.01 mol benzaldehyde in 25 mL ethanol
  2. Add 0.01 mol Ammonium Solution.
  3. Add 0.01 mol ammonium acetate.
  4. Reflux 2 hours.
  5. Cool and filter oxime.

Step 2: Reaction with Phenylhydrazine HCl

  1. Dissolve oxime in ethanol.
  2. Add phenylhydrazine hydrochloride.
  3. Add few drops acetic acid. 4. Reflux 2 hours.

Step 3: Cyclization

  1. Add 2,4dinitrophenylhydrazine.
  2. Reflux 3 hours.
  3. Cool and pour into ice cold water.
  4. Filter precipitate Purification Recrystallize from ethanol.

2. Reaction Scheme:

Step 1: Oxime FormationBenzaldehyde + NH + NHOAc? (EtOH, reflux)?

Benzaldehyde oxime

Step 2: Hydrazone FormationOxime + Phenylhydrazine HCl? (EtOH, AcOH)? Intermediate

Step 3: CyclizationIntermediate + 2,4-Dinitrophenylhydrazine? (Reflux)? 2-Phenyl-5-(benzylideneamino)-1,3,4-Oxadiazole

Compound B:  2-phenyl-5-phenylhydrazino-1,3,4-oxadiazole:

  1. Add benzaldehyde, phenylhydrazine  HCl, Ammonium Solution, and ammonium acetate into reflux flask.
  2. Add 30 mL ethanol and a few drops of acetic acid.
  3. Reflux at 75–80 °C for 4–5 hours.
  4.  Monitor using TLC.
  5. Cool and pour into icecold water.
  6. Filter pale yellow precipitate. Purification Recrystallize from ethanol. 

 Reaction Scheme: Benzaldehyde  + Phenyl hydrazine  HCl + NH + NHOAc? (EtOH, AcOH, reflux 75–80 °C, 4–5 h)? 2-Phenyl-5-(phenylhydrazino)-1,3,4-Oxadiazole Difference from  Compound 1:Product retains –NHNHPh (hydrazino group) instead of –NHPh[10,11’12’13]

Table No. 2 List Of Parameters

Name of Parameter

Comp A

Comp B

PracticalYield

2.10gm

1.80gm

Theoretical Yield

2.49g/mol

2.52g/mol

%Practical Yield

84% w/w

71% w/w

Appearance

Crystalline Solid

Light yellow crystalline solid

Color

Pale Yellow to Yellow

Off white to pale yellow

Odour

Odourless

Odourless or characteristic aromatic odour

Solubility

Soluble in ethanol, chloroform ,DMSO and DMF; sparingly soluble in water.

Soluble in ethanol, methanol and DMSO; sparingly soluble in water.

Melting Point

198-202oC

210-214 oC

Table No -3 List  Of Chemical Test

 

Sr. No.

Test

Procedure

Observation

Result

1

2 4 DNP Test

Add a2-4-DNP reagent in a sample[5,]

No Yellow / Orange Precipitate

 

 

+

2

Bromine

Water Test

A small quantity of the compound was dissolved

In ethanol and treated with bromine water[7,].

De colorization of

bromine water.

 

+

3

Ferric

Chloride Test

The compound solution was treated with a few

drops of 5%ferric chloride solution.[7]

Yellowish-green

color.

 

+

4

Schiff’s Test

Small Amount of Sample Dissolve in Ethanol and Add A Schiff’s Reagent[5]

No Pink Color

 

+

SPECTRAL  CHARACTERIZATION

FTIR

Figure No. 1 Peak of Comp A & Comp B FTIR

Table No.4: Interpretation of COMP A and COMP B.(FTIR)

Compound

FT-IR Peaks

(cm?¹)

Functional Group/ Interpretation

Observation

 

 

 

 

Compound A

3315, 3278

N-H/O-H stretching

Presence on firmed (positive

broad absorption)

3091, 3021

Aromatic C-H stretching

Aromatic ring present

2917

Aliphatic C-H  stretching

Positive for alkyl C–H

1583

Aromatic C=C stretching

Aromatic system confirmed

1494-1414

Aromatic skeletal vibration

Positive aromatic frame work

1309-1023

C-N/C-O stretching

Presence of heteroatom Linkage confirmed

975-642

Aromatic C-H bonding[11’13]

Substituted aromatic ring present

 

 

 

 

 

 

Compound B

3565, 3499

O-H/N-H stretching

Positive hydrogen-bonded Functional group

3308, 3053,

3024

Aromatic C-H stretching

Aromatic ring confirmed

1673

C=O stretching

Carbonyl group positively identified

1594, 1557,

1514

Aromatic C=C/C=N

stretching

Conjugated/aromatic system present

1489-1294

Aromatic skeletal and C-N

Stretching[11,13]

Positive C–N linkage

  H NMR

Figure No. 4 1H NMR COMP A and COMP B.

Table No.5:Assignment of COMP A and COMP B.

 

Compound

¹Hnmr (400MHZ,DMSO-D?, Δ PPM)Assignment

Assignment

Compound A

7.55–7.48 (m, 5H), 7.30–7.18(m,5H), 6.52(s, 1H)

Multiplets at δ 7.55–7.18 ppm correspond to aromatic protons of phenyl rings; singles at δ6.52 ppm assigned to azo methane proton(–CH=N–)

Compound B

8.53(s, 1H), 7.92–7.89 (m, 2H),7.54–7.18(m, 8H),7.19(s, 1H)

Singlet at δ 8.53 ppm attributed to–NH proton of hydrazino group; aromatic protons appeared as multiplets betweenδ7.92–7.18 ppm; singlet at δ7.19 ppm assigned to secondary hydrazino proton

Note –Both spectra are recorded in DMSO-d6 solvent. The common ¹HNMR solvent peaks visiblearound:δ2.50 ppm[18]

   ¹³CNMR:

 

Figure .No. 5 13CNMR (COMP A&B ).

Table No.6: Assignment of COMP A and COMP B

Compound

¹³CNMR(DMSO-d,δppm)

Assignment

 

CompoundA

167.66, 157.03, 153.95, 138.91,

133.33, 132.66, 131.82, 129.58,

128.57, 126.58, 124.04, 123.81,

115.52,111.41[17]

Oxadiazole C=Ncarbonsobserved at δ 167.66, 157.03 and 153.95

ppm; aromatic phenyl carbons appeared between δ111.41–138.91 ppm

 

CompoundB

167.69, 166.52, 151.90, 133.40,

131.29, 129.89, 129.13, 128.23,

126.42,125.88,117.91,113.43[17]

Down field signalsat δ 167.69,

166.52and151.90 ppm correspond to oxadiazole carbons; aromatic carbons resonated between δ 113.43–133.40 ppm

 Note - The characteristic solvent peakin¹³CNMR for DMSO-d6 appears around :δ39.5ppm (usually seen as a multiplet /septet due to deuterium coupling).[16’17]

Mass Spectroscop

Figure .No.6: Mass Spectroscopy (COMP A & B)

Table No.7: Interpretation of COMP A And B

COM A

COM B

Peakm/z

Interpretation

Peakm/z

Interpretation

239.06

Aromatic oxadiazole fragment

214.99

Base peak corresponding to oxadiazole fragment

283.14

Intermediate fragmention

232.02

Protonated fragment

300.17

Phenyl substituted fragment

279.21

Aromatic substituted ion

327.20

Rearranged molecular fragment

308.11

Intermediate molecular fragment

344.22

Probable molecular ion peak

387.10

Dimeric fragment

388.29

Dimeric /associated fragment

446.06

Molecular ion /adduct peak[19]

432.30

Higher molecularaggregate

 

 Interpretation Comp A

The spectrum shows characteristic fragmentation of aromatic heterocyclic compounds containing the 1,3,4-oxadiazole nucleus. The prominent peaks around 300–344 m/z support formation of substituted oxadiazole derivatives.[18’19]

 Interpretation Comp B

The intense base peak at 214 m/z suggests a stable oxadiazole-containing fragment. Peaks at higher m/z values indicate substituted aromatic systems and possible molecular ionformation.[8’9’

Biological  Test:-

1 Membrane Stabilizattion Assay (HRBC Method)

Figure No-7 HRBC Method

2 Albumin Denaturation Assay / Protrin Denaturation

      

Figure No-8 Albumin Denaturation Assay

TLC Identification

Table No-8 Tlc

Compound

 

Distance travel (in CM)

R.F Value

 

Compound

A

 

Solvent

6.4

---

Benzaldehyde

4.5

0.6

A

5.4

0.8

 

Compound    B

Solvent

6

---

Phenylhydrazine Hcl

 

4.4

0.7

B

5

0.7

Figure No 9 .Comp A         FigureNo-10Comp B

RESULTS AND DISCUSSION

The present investigation successfully achieved the synthesis of two novel oxadiazole derivatives designated as Compound A and Compound B. Both compounds were obtained as crystalline solids with satisfactory yields and good purity after recrystallization.

The percentage yield obtained for Compound A (84%) was higher than that of Compound B (71%), indicating that the multistep synthetic route employed for Compound A provided better product recovery. Physicochemical characterization revealed that both compounds were stable solids possessing distinct melting point ranges. Compound A exhibited a melting point of 198–202°C, while Compound B showed a slightly higher melting point of 210–214°C, suggesting stronger intermolecular interactions within its crystal lattice.

Qualitative chemical tests further supported the formation of the desired compounds. Positive responses in bromine water and ferric chloride tests indicated the presence of unsaturated and aromatic functionalities. The observed reactions confirmed the incorporation of heterocyclic and substituted aromatic moieties within the synthesized molecules.

FT-IR spectral analysis provided important evidence regarding the structural features of the compounds. Compound A displayed characteristic absorption bands corresponding to N–H stretching, aromatic C–H stretching, aromatic C=C vibrations, and C–N/C–O linkages. Compound B showed similar aromatic absorptions along with a prominent carbonyl stretching band, indicating the presence of additional functional group contributions. These spectral features were consistent with the proposed molecular structures.

The ¹H NMR spectra demonstrated signals attributable to aromatic protons and heterocyclic substituents. Compound A exhibited a singlet corresponding to the azomethine proton along with multiplets arising from aromatic hydrogens. Compound B showed characteristic NH proton resonances and aromatic proton signals, confirming the presence of the phenylhydrazino substituent. The chemical shift values were in good agreement with the expected proton environments.

Further structural confirmation was obtained through ¹³C NMR spectroscopy. Downfield carbon resonances corresponding to oxadiazole ring carbons were observed in both compounds. Aromatic carbon signals appeared within the expected chemical shift range, supporting successful cyclization and formation of the target heterocyclic framework.

Mass spectrometric analysis revealed molecular ion peaks and characteristic fragmentation patterns consistent with substituted 1,3,4-oxadiazole derivatives. The fragmentation profiles provided additional evidence for the molecular architecture of the synthesized compounds. The observed mass-to-charge ratios supported the proposed structures and confirmed the successful synthesis of both target molecules.

Overall, the combined physicochemical and spectral studies conclusively established the formation of the desired oxadiazole derivatives. The presence of biologically relevant functional groups and the stability of the synthesized compounds suggest their potential usefulness for future pharmacological evaluation, particularly in anti-inflammatory drug discovery programs.[14’15’18]

CONCLUSION

The present study successfully synthesized and characterized two novel 1,3,4-oxadiazole derivatives, namely 2-phenyl-5-(benzylideneamino)-1,3,4-oxadiazole and 2-phenyl-5-(phenylhydrazino)-1,3,4-oxadiazole. The synthesized compounds were obtained in good yields and exhibited satisfactory physicochemical properties. Structural elucidation using FT-IR, ¹H NMR, ¹³C NMR, and mass spectrometry confirmed the successful formation of the oxadiazole ring system and the proposed molecular structures. The spectral data demonstrated the presence of characteristic functional groups and aromatic heterocyclic frameworks. These findings indicate that the developed synthetic methods are effective for the preparation of oxadiazole-based molecules. Considering the established pharmacological significance of 1,3,4-oxadiazole derivatives, the synthesized compounds may represent promising candidates for further biological screening and optimization as potential anti-inflammatory agents.[1’11’17’16]

REFERENCES

  1. Husain A., Ajmal M. Synthesis of novel 1,3,4-oxadiazole derivatives and biological properties.
  2. Chawla G. et al. Oxadiazole scaffold in anti-inflammatory activity.
  3. Biju C.R. et al. Microwave-assisted synthesis of oxadiazoles.
  4. Pathak A. et al. Novel oxadiazole derivatives as anti-inflammatory agents.
  5. Singhai A., Gupta M.K. Oxadiazole derivatives as NSAID alternatives
  6. Mishra R. et al. 1,3,4-Oxadiazole derivatives: synthesis and pharmacological activity.International Journal of Pharmaceutical Sciences, 2011.
  7. Borg S. et al. Design, synthesis and biological evaluation of oxadiazole derivatives as anti-inflammatory agents.Bioorganic & Medicinal Chemistry, 2009.
  8. Rollas S. &Küçükgüzel ?. G.. Biological activities of hydrazone derivatives.Molecules, 2007.
  9. Akhtar T. et al. Synthesis and anti-inflammatory evaluation of substituted oxadiazoles.European Journal of Medicinal Chemistry, 2010.
  10. Holla B. S. et al. Synthesis of oxadiazole derivatives and their biological evaluation.Indian Journal of Chemistry, 2006.
  11. Kumar D. et al. Synthesis and biological evaluation of oxadiazole derivatives as anti-inflammatory agents.Bioorganic & Medicinal Chemistry Letters, 2008.
  12. Sharma P. C. et al. Oxadiazole: a biologically important scaffold.Journal of Enzyme Inhibition and Medicinal Chemistry, 2010.
  13. Patel N. B. et al. Synthesis and antimicrobial/anti-inflammatory activities of oxadiazoles.Arkivoc, 2012.
  14. Maslat A. O. et al. Synthesis and biological activity of some heterocyclic compounds.Polish Journal of Pharmacology, 2002.
  15. Abdel-Wahab B. F. et al. Synthesis and anti-inflammatory activity of heterocycles containing oxadiazole moiety.European Journal of Chemistry, 2012.
  16. Rane R. A. et al. Synthesis and evaluation of oxadiazole derivatives as anti-inflammatory agents.European Journal of Medicinal Chemistry, 2012.
  17. Gursoy A. &Terzioglu N.. Synthesis and isolation of new oxadiazole derivatives.Turkish Journal of Chemistry, 2005.
  18. Singh A. K. et al. Recent advances in 1,3,4-oxadiazole chemistry.International Journal of Research in Pharmaceutical Sciences, 2013.
  19. Zhang H. Z. et al. Design and synthesis of novel oxadiazole derivatives as anti-inflammatory agents.Bioorganic & Medicinal Chemistry Letters, 2009

Reference

  1. Husain A., Ajmal M. Synthesis of novel 1,3,4-oxadiazole derivatives and biological properties.
  2. Chawla G. et al. Oxadiazole scaffold in anti-inflammatory activity.
  3. Biju C.R. et al. Microwave-assisted synthesis of oxadiazoles.
  4. Pathak A. et al. Novel oxadiazole derivatives as anti-inflammatory agents.
  5. Singhai A., Gupta M.K. Oxadiazole derivatives as NSAID alternatives
  6. Mishra R. et al. 1,3,4-Oxadiazole derivatives: synthesis and pharmacological activity.International Journal of Pharmaceutical Sciences, 2011.
  7. Borg S. et al. Design, synthesis and biological evaluation of oxadiazole derivatives as anti-inflammatory agents.Bioorganic & Medicinal Chemistry, 2009.
  8. Rollas S. &Küçükgüzel ?. G.. Biological activities of hydrazone derivatives.Molecules, 2007.
  9. Akhtar T. et al. Synthesis and anti-inflammatory evaluation of substituted oxadiazoles.European Journal of Medicinal Chemistry, 2010.
  10. Holla B. S. et al. Synthesis of oxadiazole derivatives and their biological evaluation.Indian Journal of Chemistry, 2006.
  11. Kumar D. et al. Synthesis and biological evaluation of oxadiazole derivatives as anti-inflammatory agents.Bioorganic & Medicinal Chemistry Letters, 2008.
  12. Sharma P. C. et al. Oxadiazole: a biologically important scaffold.Journal of Enzyme Inhibition and Medicinal Chemistry, 2010.
  13. Patel N. B. et al. Synthesis and antimicrobial/anti-inflammatory activities of oxadiazoles.Arkivoc, 2012.
  14. Maslat A. O. et al. Synthesis and biological activity of some heterocyclic compounds.Polish Journal of Pharmacology, 2002.
  15. Abdel-Wahab B. F. et al. Synthesis and anti-inflammatory activity of heterocycles containing oxadiazole moiety.European Journal of Chemistry, 2012.
  16. Rane R. A. et al. Synthesis and evaluation of oxadiazole derivatives as anti-inflammatory agents.European Journal of Medicinal Chemistry, 2012.
  17. Gursoy A. &Terzioglu N.. Synthesis and isolation of new oxadiazole derivatives.Turkish Journal of Chemistry, 2005.
  18. Singh A. K. et al. Recent advances in 1,3,4-oxadiazole chemistry.International Journal of Research in Pharmaceutical Sciences, 2013.
  19. Zhang H. Z. et al. Design and synthesis of novel oxadiazole derivatives as anti-inflammatory agents.Bioorganic & Medicinal Chemistry Letters, 2009

Photo
Priyanka Chendke
Corresponding author

Department Of Pharmaceutical Chemistry Vidya Niketan College of Pharmacy, Lakhewadi, Indapur, Pune

Photo
Samrat Khedkar
Co-author

Department Of Pharmaceutical Chemistry Vidya Niketan College of Pharmacy, Lakhewadi, Indapur, Pune

Photo
Mahesh Pingale
Co-author

Department Of Pharmaceutical Chemistry Vidya Niketan College of Pharmacy, Lakhewadi, Indapur, Pune

Photo
Nikita Pol
Co-author

Department Of Pharmaceutical Chemistry Vidya Niketan College of Pharmacy, Lakhewadi, Indapur, Pune

Photo
Om Walke
Co-author

Department Of Pharmaceutical Chemistry Vidya Niketan College of Pharmacy, Lakhewadi, Indapur, Pune

Samrat Khedkar, Mahesh Pingale, Priyanka Chendke, Nikita Pol, Om Walke, Synthesis of Novel 1,3,4-Oxadiazole Derivative as Anti-Inflammatory Agents, Int. J. of Pharm. Sci., 2026, Vol 4, Issue 6, 7176-7186. https://doi.org/10.5281/zenodo.21028356

More related articles
Formulation and Evaluation of a Natural Nutritiona...
Sanika Soor, Nilesh Chachda, Snehal Vaidya, Sapna Akhade...
RP-HPLC Method Development and Validation for the ...
Dr. P. V. Madhavi Latha , Dr. P Uma Devi, K Suvarna, P. Siva Lali...
Development and Evaluation of Herbal Gel Formulati...
Ajeet Kumar Yadav, Dr. Pavan Kumar, Dr. Vipin Kesarwani, Vasim Kh...
4D Bioprinting: Shaping the Future of Dynamic and Smart Tissue Regeneration...
Tanaya Markande, Snehal Nage , Pranjali Narwade , Aarti More, Sanika Nalande, Sumeet Bhilwade ...
Related Articles
A Review on Natural Disintegrating Agents...
S.T.V. Raghavamma, P. Suma Sri, M. Pavani, G. Naga Sai Sandeepthi, K. Hemavarshini...
Formulation And Evaluation of Floating Drug Delivery System of Pirfenidone...
Mahesh Reddy, Shweta Jadhav, Sakshi Dive, Tanishq Padole ...
Formulation and Evaluation of a Natural Nutritional Bar...
Sanika Soor, Nilesh Chachda, Snehal Vaidya, Sapna Akhade...
More related articles
Formulation and Evaluation of a Natural Nutritional Bar...
Sanika Soor, Nilesh Chachda, Snehal Vaidya, Sapna Akhade...
RP-HPLC Method Development and Validation for the simultaneous estimation of Cob...
Dr. P. V. Madhavi Latha , Dr. P Uma Devi, K Suvarna, P. Siva Lalitha...
Development and Evaluation of Herbal Gel Formulations Using Advanced Analytical ...
Ajeet Kumar Yadav, Dr. Pavan Kumar, Dr. Vipin Kesarwani, Vasim Khan...
Formulation and Evaluation of a Natural Nutritional Bar...
Sanika Soor, Nilesh Chachda, Snehal Vaidya, Sapna Akhade...
RP-HPLC Method Development and Validation for the simultaneous estimation of Cob...
Dr. P. V. Madhavi Latha , Dr. P Uma Devi, K Suvarna, P. Siva Lalitha...
Development and Evaluation of Herbal Gel Formulations Using Advanced Analytical ...
Ajeet Kumar Yadav, Dr. Pavan Kumar, Dr. Vipin Kesarwani, Vasim Khan...